Stueland Katherine sold WGS
September 30, 2025 · Form 4 insider transaction
Stueland Katherine sold 136 shares of GeneDx Holdings Corp. at $113.68 per share, a transaction worth $15.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024.; Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 1,720 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 444,539 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms.